Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma ; volume:15 ; number:12 ; day:16 ; month:12 ; year:2024 ; pages:1-3 ; date:12.2024
Cell death & disease ; 15, Heft 12 (16.12.2024), 1-3, 12.2024

Creator: Li, Jin
Li, Zhongwu
Wu, Yaping
Wang, Yanling
Wang, Dongmiao
Zhang, Wei
Yuan, Hua
Ye, Jinhai
Song, Xiaomeng
Yang, Jianrong
Jiang, Hongbing
Cheng, Jie

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41419-024-07280-7

URN: urn:nbn:de:101:1-2502272135565.420164550445

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:19 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Li, Jin
Li, Zhongwu
Wu, Yaping
Wang, Yanling
Wang, Dongmiao
Zhang, Wei
Yuan, Hua
Ye, Jinhai
Song, Xiaomeng
Yang, Jianrong
Jiang, Hongbing
Cheng, Jie
SpringerLink (Online service)

Other Objects (12)

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hochschulschrift

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hochschulschrift

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hochschulschrift

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction: The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib

Hippo-YAP/TAZ signaling in neural crest development and neuroblastoma

Hippo signaling activates hedgehog signaling by Taz-driven Gli3 processing

TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression

Targeting the YAP/TAZ Hippo signaling pathway for oral cancer treatment

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway

VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein

Related objects

Reset password